Agilent Technologies, Inc. - Diagnostics and Genomics SureSelectXT NCC oncopanel, 16 rxn
The SureSelectXT NCC Oncopanel, 16 reactions (Agilent part number 931195), is a targeted next-generation sequencing (NGS) panel designed for comprehensive cancer research. This panel enables the enrichment and sequencing of key cancer-related genes, facilitating the detection of somatic mutations in tumor samples. Utilizing Agilent's SureSelectXT technology, the kit provides high sensitivity and specificity for variant detection, supporting robust and reproducible results. The kit is optimized for use with low-input DNA and is compatible with Illumina sequencing platforms, making it suitable for a wide range of oncology research applications.